145 results on '"Kleiman, Neal S."'
Search Results
2. Will Machine Learning Help Us Predict Strokes During Percutaneous Valve Procedures?
3. At Arm's Length: Radiation Safety During Radial Percutaneous Coronary Intervention.
4. ADVANCES IN TRANSCATHETER AORTIC VALVE REPLACEMENT.
5. What’s New with TAVR? An Update on Device Technology.
6. Transcatheter Aortic Valve Implantation: Long-Term Outcomes and Durability.
7. Delayed Coronary Obstruction After TAVR: A Call for Vigilance.
8. Expanding the Roster: Developing New Inhibitors of Intravascular Thrombosis.
9. IMPACT OF RENIN-ANGIOTENSIN SYSTEM INHIBITORS ON CLINICAL OUTCOMES IN PATIENTS WITH SEVERE SYMPTOMATIC AORTIC STENOSIS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT WITH A SELF-EXPANDING BIOPROSTHESIS.
10. CHANGES OVER TIME IN QUALITY OF LIFE IN INTERMEDIATE RISK AORTIC STENOSIS PATIENTS UNDERGOING TAVR OR SAVR IN THE SURTAVI TRIAL.
11. Are We There Yet? Deciding When It Is Safe (and Wise) to Stop Clopidogrel after Stent Implantation.
12. Cautionary Tale or Exploratory Trek - Predicting Mortality Using the DAPT Score.
13. A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary Intervention.
14. Grabbing the Horns of a Dilemma: The Duration of Dual Antiplatelet Therapy After Stent Implantation.
15. BALANCING HEMOSTASIS AND THROMBOSIS IN INTERVENTIONAL VASCULAR MEDICINE AND SURGERY.
16. Are Immature Platelets Growing Up?: Toward a New Marker of Antiplatelet Drug Resistance.
17. Assessment, Mechanisms, and Clinical Implication of Variability in Platelet Response to Aspirin and Clopidogrel Therapy
18. Watching a Procedure Evolve: Sequential Findings From the TVT Registry.
19. Platelets: Developmental biology, physiology, and translatable platforms for preclinical investigation and drug development.
20. Circulating Endothelial Progenitor Cells and Coronary Collaterals in Patients with Non-ST Segment Elevation Myocardial Infarction.
21. Long-term Efficacy of Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade vs Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Revascularization: REPLACE-2 Randomized Trial.
22. Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non–ST-elevation acute coronary syndromes.
23. When Prevention is Truly Better than Cure: Contrast-Associated Acute Kidney Injury in Percutaneous Coronary Intervention.
24. Primary and secondary safety endpoints from IMPACT II.
25. Percutaneous transluminal coronary angioplasty in octogenarians.
26. Bringing it all together: integration of physiology with anatomy during cardiac catheterization.
27. Bringing It All Together: Integration of Physiology With Anatomy During Cardiac Catheterization ⁎ [⁎] Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
28. Clopidogrel and Calcium-Channel Antagonists: Another Drug–Drug Interaction for the Ever-Wary Clinician? ⁎ [⁎] Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
29. Will Measuring Vasodilator-Stimulated Phosphoprotein Phosphorylation Help Us Optimize the Loading Dose of Clopidogrel? ⁎ [⁎] Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
30. Measuring Troponin Elevation After Percutaneous Coronary Intervention: Ready for Prime Time? ⁎ [⁎] Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
31. Platelets, the cardiologist, and coronary artery disease: moving beyond aggregation
32. Combination therapy for acute myocardial infarction*<FN ID="FN1"><NO>*</NO>Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.</FN>: Will it survive?*
33. VWF, ADAMTS13, and acute coronary syndromes.
34. At 5 years, transcatheter aortic valve replacement had similar rates of mortality and stroke as surgical aortic valve replacement in high-risk patients.
35. Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients.
36. Von Willebrand factor and the aortic valve: Concepts that are important in the transcatheter aortic valve replacement era.
37. Soluble CD40 Ligand in Acute Coronary Syndromes.
38. Mechanisms of Death in Low-Risk Patients After Transcatheter or Surgical Aortic Valve Replacement.
39. Clinical Impact of Tricuspid Regurgitation on Transcatheter Edge-to-Edge Mitral Valve Repair for Mitral Regurgitation.
40. QCA to Guide Treatment of Inter-Clip Mitral Regurgitation Between Two Previously Implanted MitraClips.
41. National Trends and Outcomes of Surgical Aortic Valve Replacement With Concomitant Mitral Valve Surgery.
42. Trends in Outcomes of Hospitalized Adults Undergoing Percutaneous Balloon Mitral Valvuloplasty in the United States.
43. Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi.
44. 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement.
45. 2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients.
46. Statin Therapy in Patients With Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry)
47. Statin Therapy in Patients With Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry).
48. A MULTIDISCIPLINARY APPROACH TOWARDS RESECTING A MOBILE, CONTINUOUS LEIOMYOMA TO THE HEART.
49. AN UNUSUAL SUSPECT- METAL ALLERGY UNRAVELED IN TAVR VALVE DYSFUNCTION.
50. TRANSCATHETER AORTIC VALVE REPLACEMENT IN PREGNANCY VIA TRANS-CAROTID APPROACH.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.